Ocumetics says first-in-human Group One intraocular lens patients reach 12-month follow-up milestone

• Ocumetics reported its first-in-human Group One lens-implant patients reached 12-month follow-up; results will be released shortly.
• Earlier follow-ups showed vision gains translating into everyday benefits, supporting continued development of the accommodating intraocular lens.
• Safety and implantation performance tracked to internal benchmarks through six months, underpinning plans to expand clinical work.
• Preparation began for Group Two surgeries to evaluate safety, distance vision, and near-vision performance in a broader study focus.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ocumetics Technology Corp. published the original content used to generate this news brief via TheNewswire (Ref. ID: 202609170920TNWSWRCACNPR_____1AlpFlj8Q) on September 17, 2026, and is solely responsible for the information contained therein.